Regenxbio (RGNX) Preferred Dividend Payments (2014 - 2015)
Regenxbio's (RGNX) quarterly Preferred Dividend Payments came in at $2.5 million in Q2 2015, up 431.39% quarter-over-quarter from -$755000.0 in Q1 2015.
Regenxbio (RGNX) Preferred Dividend Payments (2014 - 2015) Analysis & Trends
Regenxbio's Preferred Dividend Payments history runs 2 years deep, the most recent figure standing at $2.5 million for Q2 2015.
- On a quarterly basis, Preferred Dividend Payments changed N/A year-over-year to $2.5 million in Q2 2015; TTM through Dec 2015 was $1.7 million, a N/A change from a year earlier, with the FY2015 full-year figure at $1.7 million, up 114.36% from the prior year.
- Preferred Dividend Payments rose to $2.5 million in Q2 2015 per RGNX's latest filing, from -$755000.0 in the prior quarter.
- Across five years, Preferred Dividend Payments topped out at $2.5 million in Q2 2015 and bottomed at -$755000.0 in Q1 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Regenxbio | 528.62 Mn | 298.55 Mn | 21.22 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2015 | 2.50 Mn |
| Mar 31, 2015 | -755,000.00 |
| Dec 31, 2014 | 223,000.00 |
| Sep 30, 2014 | 126,000.00 |